Skip to main content
. 2022 May 19;20:6. doi: 10.1186/s12948-022-00171-2

Table 4.

Adverse events reported by patients receiving dupilumab (N = 74)

Adverse events N (%)
At least 1 adverse event (AE) 25 (33.8)
Asthenia 6 (8.1)
Arthralgia 5 (6.8)
Conjunctivitis 4 (5.4)
Injection-site reaction 3 (4.1)
Nausea 3 (4.1)
Abdominal pain 2 (2.7)
Headache 2 (2.7)
Diarrhea 1 (1.4)
Dizziness 1 (1.4)
Orofacial HSV reactivation 1 (1.4)
Weight gain 1 (1.4)
Any AE leading to discontinuation of study 0 (0)

HSV Herpes simplex virus